420 related articles for article (PubMed ID: 2527034)
21. A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis.
Schneider M; Nesheim M
J Biol Chem; 2004 Apr; 279(14):13333-9. PubMed ID: 14715655
[TBL] [Abstract][Full Text] [Related]
22. Acoustic determination of performance and equivalence of plasminogen activators.
Ghazali M; Hayward GL
Anal Bioanal Chem; 2008 Nov; 392(5):897-902. PubMed ID: 18759103
[TBL] [Abstract][Full Text] [Related]
23. Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.
Sakata Y; Aoki N
J Clin Invest; 1982 Mar; 69(3):536-42. PubMed ID: 7199538
[TBL] [Abstract][Full Text] [Related]
24. Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation.
Hare TR; Gardell SJ
Thromb Haemost; 1992 Aug; 68(2):165-9. PubMed ID: 1412162
[TBL] [Abstract][Full Text] [Related]
25. Staphylokinase as a plasminogen activator component in recombinant fusion proteins.
Szarka SJ; Sihota EG; Habibi HR; Wong S
Appl Environ Microbiol; 1999 Feb; 65(2):506-13. PubMed ID: 9925575
[TBL] [Abstract][Full Text] [Related]
26. Kinetic properties of the activator complexes plasmin--staphylokinase and plasmin(ogen)--streptokinase in vitro.
Sazonova IY; Aisina RB; Muhametova LI; Varfolomeyev SD
Biochemistry (Mosc); 1999 Jan; 64(1):66-74. PubMed ID: 9986915
[TBL] [Abstract][Full Text] [Related]
27. Fibrin-targeted plasminogen activation by plasminogen activator, PadA, from Streptococcus dysgalactiae.
Singh S; Bhando T; Dikshit KL
Protein Sci; 2014 Jun; 23(6):714-22. PubMed ID: 24639287
[TBL] [Abstract][Full Text] [Related]
28. Fibrin-associated plasminogen activation in alpha 2-plasmin inhibitor deficiency.
Aoki N; Sakata Y; Ichinose A
Blood; 1983 Nov; 62(5):1118-22. PubMed ID: 6626743
[TBL] [Abstract][Full Text] [Related]
29. The conversion of streptokinase-plasminogen complex to SK-plasmin complex in the presence of fibrin or fibrinogen.
Takada Y; Takada A
Thromb Res; 1989 Apr; 54(2):133-9. PubMed ID: 2526391
[TBL] [Abstract][Full Text] [Related]
30. The mechanism of a bacterial plasminogen activator intermediate between streptokinase and staphylokinase.
Sazonova IY; Houng AK; Chowdhry SA; Robinson BR; Hedstrom L; Reed GL
J Biol Chem; 2001 Apr; 276(16):12609-13. PubMed ID: 11278483
[TBL] [Abstract][Full Text] [Related]
31. Enhanced plasminogen activation by staphylokinase in the presence of streptokinase beta/betagamma domains: plasminogen kringles play a role.
Dahiya M; Rajamohan G; Dikshit KL
FEBS Lett; 2005 Mar; 579(7):1565-72. PubMed ID: 15757642
[TBL] [Abstract][Full Text] [Related]
32. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
Veremeenko KN; Kizim AI
Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
[TBL] [Abstract][Full Text] [Related]
33. Interaction of staphylokinase with different molecular forms of plasminogen.
Lijnen HR; Van Hoef B; Collen D
Eur J Biochem; 1993 Jan; 211(1-2):91-7. PubMed ID: 8425556
[TBL] [Abstract][Full Text] [Related]
34. Functional properties of recombinant staphylokinase variants obtained by site-specific mutagenesis of methionine-26.
Schlott B; Hartmann M; Gührs KH; Birch-Hirschfeld E; Gase A; Vettermann S; Collen D; Lijnen HR
Biochim Biophys Acta; 1994 Feb; 1204(2):235-42. PubMed ID: 8142464
[TBL] [Abstract][Full Text] [Related]
35. Enhanced activation of bound plasminogen on Staphylococcus aureus by staphylokinase.
Mölkänen T; Tyynelä J; Helin J; Kalkkinen N; Kuusela P
FEBS Lett; 2002 Apr; 517(1-3):72-8. PubMed ID: 12062412
[TBL] [Abstract][Full Text] [Related]
36. The fibrinolytic system in man.
Collen D; Lijnen HR
Crit Rev Oncol Hematol; 1986; 4(3):249-301. PubMed ID: 2420482
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of staphylokinase on platelet aggregation.
Suehiro A; Oura Y; Ueda M; Kakishita E
Thromb Haemost; 1993 Nov; 70(5):834-7. PubMed ID: 7510426
[TBL] [Abstract][Full Text] [Related]
38. Staphylokinase: fibrinolytic properties and current experience in patients with occlusive arterial thrombosis.
Collen D; Lijnen HR; Vanderschueren S
Verh K Acad Geneeskd Belg; 1995; 57(3):183-96; discussion 196-8. PubMed ID: 7483814
[TBL] [Abstract][Full Text] [Related]
39. Effect of staphylokinase concentration of plasminogen activation.
Arai K; Mimuro J; Madoiwa S; Matsuda M; Sako T; Sakata Y
Biochim Biophys Acta; 1995 Aug; 1245(1):69-75. PubMed ID: 7654768
[TBL] [Abstract][Full Text] [Related]
40. Plasminogen activation by staphylokinase enhances local spreading of S. aureus in skin infections.
Peetermans M; Vanassche T; Liesenborghs L; Claes J; Vande Velde G; Kwiecinksi J; Jin T; De Geest B; Hoylaerts MF; Lijnen RH; Verhamme P
BMC Microbiol; 2014 Dec; 14():310. PubMed ID: 25515118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]